Jonathan has almost 20 years of experience helping biopharmaceutical companies make better strategic decisions. His primary focus has been in the areas of pricing and market access and commercial strategy. Jonathan brings particularly deep expertise in understanding rapidly changing markets.
In his role as a Principal with ClearView Healthcare Partners, Jonathan helps clients navigate evolving and uncertain market environments. His areas of therapeutic focus include oncology and rare diseases. Jonathan also has recognized expertise in the digital medicine space. He recently spoke on commercial models for digital companies at the 2020 DTx West conference and at the European Pricing Forum. He has also lectured on valuation approaches and techniques at the Massachusetts Biotechnology Council, and has co-authored articles published in the Journal of Clinical Pathways, PharmaVOICE and In Vivo.
Before joining ClearView, Jonathan served as Managing Director and Head of Office for Eversana Management Consulting (fka Promidian Consulting). Jonathan began his career in life science at Vertex Pharmaceuticals, and has held leadership roles at Putnam Associates, IQVIA (fka The Amundsen Group), and L.E.K. Consulting.
Jonathan earned Bachelor of Arts degrees in economics and geology from Dartmouth College and an MBA from Harvard Business School.
Debbi Amanti Belanger